Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Phac5g02462 | ATGCATATTTTGCATGTTTATGTTTTAGGATTCATCAGCATAGATTGCGGAGCCGAAGCAGGTGTCAACTATACTGAGCCATCACTAGAAATAAATTACGTTTCTGATGCAAATTTCATAAATACGGGTGTGAGAGGGATAATAACATCTGAAGAGATCAGCACACACACTCAACGACAACTGTGGAGGCTGAGAAGCTTCCCGGAAGGAAAAAGGAACTGCTACAAAATCAGCGTCACAAGAGGCTCTAGATATCTCATCCGCACCACTTTTCTGTATGGAAATTATGATGGCCAAAATATGCTACCACAGTTTGATCTTCTTCTTGGAGCTAACCTGTGGGGTACAGTGACTATAGACAATGCATCCATTGCCAAATCCAATGAGATCATACATGTACTTTCACTGGATTTCGTACAAATCTGTCTGGTAAACACAGGAAAGGGTACACCATTTATAACAGCCATTGAATTCAGGACTTTGATAAATCGTACATACGTCACTCCATTGGTATCGCTGGAATATTACATGCGGTGCGATTTGGGTTCTGACAGAAGCTACAGGTACTGGGCTGATGATTATGATCGTATCTGGTATACCTGTGACTTCGAAGAAGATTGGACACAGCTAAATGCCTCGATTCCTGACGATTCTTTTGTTGATAACGATTACAATCCGGGAGCAACCATCATGAGCACCGCAGTTACACCAGCAAACGGTAGTGCTCCGTTGGTAATAAGCTGGGAGCCAGAAGATGAAACTGAAGAATTCTATGTGTACTTGCACTTCATGGAGCTTCAAGTGTTAACCGAGAATCAGACAAGACAATTCAACATCAACGGTGCCATATGGTTTAAAAATTATTCTCCGTGGTACATGAGCGTGTTCACTTTATATAGCAGGTCAGCCAGCAGCGGGAAAGAAATTAAAATTTCCCTGGAGAGGACCAAAAATTCCACCCTACCTCCCATCCTCAATGCCATTGAAATTTACAGAGTAAAACAATTCCATCAATCTGATACATTCCAAGGAGATGTCGATGCGATTACAAGCATCAAGTCAGTTTATGCGGTGACAAGAGATTGGCAAGGTGATCCATGCGCCCCTGCAGCCTACTTGTGGAATGGTGTCAATTGTTCTTATCACGGAATTGAATTCCCAAGAATCACAGCTTTGAATTTATCTTCAAGTGGATTGCATGGAAAGATTGACCCTTCAATTTCAAATCTCACCATGCTGGAGATGTTGGATTTATCAAACAATAGCTTAAACGGTGAAATTCCTGATTTTCTCTCACAACTGCAACACTTAAAGATCCTAAACTTGGAGAAGAATAACCTCTCTGGTTTGATTCCACCAGCACTAAATAAAGATTCCCTTCTACTACGTGTCGACCAAAATCCATATCTATGTGAAACTGATCAATGCAACAAGAAGAAAAACAATAGCACTGTTACGCCCATAGTAGCATCAGTTGGCGGGGTTTTGATCTTTGTGGTAGTAATGGCAGCTATATTGTGGACCGCTAAAAGAAGAAAAGCTAAAGCTTTGATGTTAAAAAAGGATCAAAGTGCCATATCACCGCAATACACTGAACAAAATGATTCCTCACTTCGATTCCAAAAACAAATATATTCATACTCTGATATCATTCAAATCACCAACAATTTCACTACAATTGTTGGTAAAGGAGGATTTGGAACAGTTTATCTGGGCTATATCGAAGACACTCCAGTTGCAGTGAAAATGCTTTCCCCATCATCTGTTCATGGTTATCAACAATTTCAAGCAGAGGTTAAACTTCTTATGAGAGTTCATCACAAAAATTTGACATCCCTTGTTGGTTACTGTAATGAAGGGACCAATAAGGGTCTCGTATACGAGTACATGGCCAATGGAAACTTACAAGAACATCTCTCTGGTAAACGAAGCAAAAGAAATTTCTTGAGCTGGGAAAAGAGACTTCGAATCGCAGTGGATGCAGCCTCAGGATTGGAGTATCTGCAAAATGGTTGTAAGCCACCAATATTCCACAGAGATGTAAAATCTACAAACATCTTGTTGAATGAACACCTCCATGCAAAATTATCTGATTTTGGACTGTCCAAAGTTGTCCTAACAGATGAGGGAACTCATGTGTCAACTGTCATTGCTGGTACTCCTGGTTATCTAGACCCTGAATACTACCTAACCAGTAGATTAACAGAGAAGAGCGACGTTTATAGCTTTGGCGTTGTGCTTTTAGAGATAATCACAGGGCAACCAGTGATAGCAAAGAATGAGGAAAAAAGTCACATAAGTGAATGGGTTAGGTCCTTGATTGGGAAAGGTGATATCAATGCTATTGTTGACTCAAGGTTAGAAGGAGAGTTTGATAGTAACTCAGTTTGGAAAGTAGTAGAAATAGCAATGGCATGTGTATCTCCAAATCCCAACAGAAGGCCAATCATAAGCGTGGTAGTGAGATTCATCAGCATAGATTGCGGAGCCGAAGCAGGTGTCAACTATACCGAGCCATCATTAGACATAAATTATGTTTCAGATGCAAATTTCATAAATACTGGTGTGAGAGGGATAATAACATCTGAAGAGATCAGCAGACAGAGTCAACGACAACTGTGGAGGCTGAGAAGCTTCCCAGAAGGAAAAAGAAACTGCTACAAAATAAACGTCACAAGAGGCTCTAATTATCTCATCCGCACTGTTTTTCTGTATGGAAATTATGATGGCCGAAATATGCTACCACAGTTTGATCTTCTTCTGGGACCTAACCTGTGGGATACCGTCACTATAGACAATGCATCCATTGGCCAATCCAATGAGATCATACATGTACCTTCAATGGATTTCATACAAATCTGTCTGGTTAACACAGGAAATGGTACACCATTTATAACAGCCATTGAATTCAGGACTTTGAAAAATGATACATACGTCACCGAATCGGGATCACTGGAACTTTATAATTACCTGCGATGCGATTTGGGTTCTAACAGAGGCTACAGGTACTGGTCTGATGTTTATGATCGTTACTGGTATACCTGTGACTTCAAGGAAGATTGGACACAGCTAAGTGCTTCGATTTCAGATGATTCTTTTGATGAGAACGATTACAAACCGGGAACTACCATCATGAGCACCGCAGTTACACCAGCAAATGGTAGTGCTCCGTTGGTAATAAGCTGGGAGCCAGAAGATGAAACTCAGGAATTCTATGTGTACATGCACTTCACGGAGATCCAGGTGTTAACCAAGAATCAGACAAGACAATTCAACATCACCAAGAACGGTGACTCAGGGTGGGGGTTTCAAAATCTTTCTCCACAGTACCAGAGTGTCAATACTATATATACCCCGTCAGCCATCAGCGGAAAAGTAATTACATATTCACTGGAGAGGACCGAAAATTCTACCCTGCCACCCATCATCAATGCCATTGAAATTTACAGAGTAAAACAATTTCATCAATCTGATACATTCCAAGGAGATGTCGATGCGATTACAAGCATCAAGTCAGTTTATGCGGTGACAAGAGATTGGGAAGGTGATCCATGCGCCCCTGCAGCTTACTTGTGGGATGGTCTCAATTGTTCTTATCACGGAATTGAATCCCCAAGAATCACAGTTTTGAATTTATCTTCAAGTGGATTGCATGGAAAGATTAACCCTTCAATTTCAAATCTCACCATGCTGGAGATATTGGATTTATCAAACAATAGCTTAAACGGTGAAATTCCTGATTTTCTGTCACAACTGCAGCACTTAAAGATCCTAAACTTGGAGAAGAATAACCTCTCTGGTTTAATTCCACCAGCACTAAATAAAGATTCCCTCCTACTACGTGTTGACCAAAATCCATATCTCTGTGAACCTGATCAATGCAACAAGAAGAAAAACAAGAAACACAATAGCATTGTTACACCCATAGTAGCATCAGTTGGCGGGGTTTTGGTCCTTCTGGTAGTAGCTGCAGCTATATTGTGGACCGCTAAAAGAAGAAAAGCTAAAGCAGCTTTGATGTTAAAAAAGGATCAAAGTGCCATATCACCGCAATACACTGAACCAAATGATTCATCACTGCAATTCCAAAAACAAATATATTCATACTCTGATATCATTAAAATCACCAACAATTTCACTACAATTGTTGGTAAAGGAGGATTTGGAACAGTTTATCTGGGCTATATCGAAGACACTCCAGTTGCAGTCAAAATGCTTTCCCCATCTTCTGTTCATGGTTATCAACAATTTCAAGCAGAGGTTAAACTTCTTATGAGAGTTCATCACAAAAATTTGACCTCCCTTGTTGGTTACTGTAATGAAGGAACCAATAAGGGTCTCGTATATGAGTACATGGCCAACGGAAACTTACAACAACATCTCTCTGGTAAACGAAGCAAAACAAGTTTCTTCAGCTGGGAAAAGAGACTTCGAATCGCAGTGGATGCAGCCTCAGAGATAATCACAGGGCAACCAGTGATAGCGAAGAATGAAGAAAAAAGTCACATAAGTGAATGGGTTAGGTCCTTGATTGGGAAAGGTGATATCAATGCCATTGTTGACTCAAGGTTAGAAGGAGAGTTTGATAGTAACTCAGTATGGAAAGCAGTAGAAATAGCAACGGCTTGTGTATCTCCAATCAGCAACAGAAGGCCAAGCATAAGTGTGGTATTGAGTGAACTGAAGGAGTCTTTATCTTTAGCAATGGAATTAGCTCAAACTAAAGATAGAAGTAATGGTAGAGTTTATTTCCATTTACAATATATATTGATTGATTGA | 4779 | 0.402 | MHILHVYVLGFISIDCGAEAGVNYTEPSLEINYVSDANFINTGVRGIITSEEISTHTQRQLWRLRSFPEGKRNCYKISVTRGSRYLIRTTFLYGNYDGQNMLPQFDLLLGANLWGTVTIDNASIAKSNEIIHVLSLDFVQICLVNTGKGTPFITAIEFRTLINRTYVTPLVSLEYYMRCDLGSDRSYRYWADDYDRIWYTCDFEEDWTQLNASIPDDSFVDNDYNPGATIMSTAVTPANGSAPLVISWEPEDETEEFYVYLHFMELQVLTENQTRQFNINGAIWFKNYSPWYMSVFTLYSRSASSGKEIKISLERTKNSTLPPILNAIEIYRVKQFHQSDTFQGDVDAITSIKSVYAVTRDWQGDPCAPAAYLWNGVNCSYHGIEFPRITALNLSSSGLHGKIDPSISNLTMLEMLDLSNNSLNGEIPDFLSQLQHLKILNLEKNNLSGLIPPALNKDSLLLRVDQNPYLCETDQCNKKKNNSTVTPIVASVGGVLIFVVVMAAILWTAKRRKAKALMLKKDQSAISPQYTEQNDSSLRFQKQIYSYSDIIQITNNFTTIVGKGGFGTVYLGYIEDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLTSLVGYCNEGTNKGLVYEYMANGNLQEHLSGKRSKRNFLSWEKRLRIAVDAASGLEYLQNGCKPPIFHRDVKSTNILLNEHLHAKLSDFGLSKVVLTDEGTHVSTVIAGTPGYLDPEYYLTSRLTEKSDVYSFGVVLLEIITGQPVIAKNEEKSHISEWVRSLIGKGDINAIVDSRLEGEFDSNSVWKVVEIAMACVSPNPNRRPIISVVVRFISIDCGAEAGVNYTEPSLDINYVSDANFINTGVRGIITSEEISRQSQRQLWRLRSFPEGKRNCYKINVTRGSNYLIRTVFLYGNYDGRNMLPQFDLLLGPNLWDTVTIDNASIGQSNEIIHVPSMDFIQICLVNTGNGTPFITAIEFRTLKNDTYVTESGSLELYNYLRCDLGSNRGYRYWSDVYDRYWYTCDFKEDWTQLSASISDDSFDENDYKPGTTIMSTAVTPANGSAPLVISWEPEDETQEFYVYMHFTEIQVLTKNQTRQFNITKNGDSGWGFQNLSPQYQSVNTIYTPSAISGKVITYSLERTENSTLPPIINAIEIYRVKQFHQSDTFQGDVDAITSIKSVYAVTRDWEGDPCAPAAYLWDGLNCSYHGIESPRITVLNLSSSGLHGKINPSISNLTMLEILDLSNNSLNGEIPDFLSQLQHLKILNLEKNNLSGLIPPALNKDSLLLRVDQNPYLCEPDQCNKKKNKKHNSIVTPIVASVGGVLVLLVVAAAILWTAKRRKAKAALMLKKDQSAISPQYTEPNDSSLQFQKQIYSYSDIIKITNNFTTIVGKGGFGTVYLGYIEDTPVAVKMLSPSSVHGYQQFQAEVKLLMRVHHKNLTSLVGYCNEGTNKGLVYEYMANGNLQQHLSGKRSKTSFFSWEKRLRIAVDAASEIITGQPVIAKNEEKSHISEWVRSLIGKGDINAIVDSRLEGEFDSNSVWKAVEIATACVSPISNRRPSISVVLSELKESLSLAMELAQTKDRSNGRVYFHLQYILID* | 1593 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Phac5g02462 | 1592 | SUPERFAMILY | L domain-like | 1161 | 1275 | - | - | |
Phac5g02462 | 1592 | ProSiteProfiles | Protein kinase domain profile. | 555 | 826 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac5g02462 | 1592 | Gene3D | Phosphorylase Kinase; domain 1 | 542 | 629 | - | - | |
Phac5g02462 | 1592 | PANTHER | OS07G0107800 PROTEIN-RELATED | 12 | 821 | - | - | |
Phac5g02462 | 1592 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 676 | 688 | IPR008271 | GO:0004672|GO:0006468 | |
Phac5g02462 | 1592 | Gene3D | Ribonuclease Inhibitor | 347 | 471 | IPR032675 | - | |
Phac5g02462 | 1592 | Gene3D | Ribonuclease Inhibitor | 1165 | 1288 | IPR032675 | - | |
Phac5g02462 | 1592 | FunFam | Leucine-rich repeat receptor-like kinase | 1163 | 1291 | - | - | |
Phac5g02462 | 1592 | SUPERFAMILY | Protein kinase-like (PK-like) | 533 | 822 | IPR011009 | - | |
Phac5g02462 | 1592 | ProSitePatterns | Protein kinases ATP-binding region signature. | 561 | 582 | IPR017441 | GO:0005524 | |
Phac5g02462 | 1592 | Pfam | Protein tyrosine and serine/threonine kinase | 558 | 822 | IPR001245 | GO:0004672|GO:0006468 | |
Phac5g02462 | 1592 | Pfam | Protein tyrosine and serine/threonine kinase | 1380 | 1485 | IPR001245 | GO:0004672|GO:0006468 | |
Phac5g02462 | 1592 | CDD | STKc_IRAK | 561 | 822 | - | - | |
Phac5g02462 | 1592 | CDD | TM_EGFR-like | 481 | 513 | - | - | |
Phac5g02462 | 1592 | FunFam | LRR receptor-like serine/threonine-protein kinase IOS1 | 630 | 834 | - | - | |
Phac5g02462 | 1592 | SUPERFAMILY | Protein kinase-like (PK-like) | 1350 | 1485 | IPR011009 | - | |
Phac5g02462 | 1592 | ProSiteProfiles | Protein kinase domain profile. | 1377 | 1592 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac5g02462 | 1592 | Pfam | Leucine Rich Repeat | 1254 | 1273 | IPR001611 | GO:0005515 | |
Phac5g02462 | 1592 | Pfam | Leucine Rich Repeat | 436 | 455 | IPR001611 | GO:0005515 | |
Phac5g02462 | 1592 | ProSitePatterns | Protein kinases ATP-binding region signature. | 1383 | 1404 | IPR017441 | GO:0005524 | |
Phac5g02462 | 1592 | Pfam | Malectin-like domain | 826 | 1151 | IPR024788 | - | |
Phac5g02462 | 1592 | Pfam | Malectin-like domain | 14 | 333 | IPR024788 | - | |
Phac5g02462 | 1592 | SMART | serkin_6 | 555 | 824 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac5g02462 | 1592 | Gene3D | Transferase(Phosphotransferase) domain 1 | 630 | 830 | - | - | |
Phac5g02462 | 1592 | Gene3D | Transferase(Phosphotransferase) domain 1 | 1487 | 1583 | - | - | |
Phac5g02462 | 1592 | Gene3D | - | 476 | 516 | - | - | |
Phac5g02462 | 1592 | FunFam | Leucine-rich repeat receptor-like kinase | 345 | 473 | - | - | |
Phac5g02462 | 1592 | Gene3D | Transferase(Phosphotransferase) domain 1 | 1351 | 1486 | - | - | |
Phac5g02462 | 1592 | SUPERFAMILY | L domain-like | 349 | 457 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Phac5g02462 | Phac-Chr5 | 42697231 | 42711484 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Phac5g02462 | 10 | 857 | Receptor kinase-like Gene Family | AT1G51800 | 47.079 | 0.0 | 781 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-I-1 | Phac5g02462 | Malectin_like | 2.2e-110 | CL0202 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Phac5g02462 | - | - | pvu:PHAVU_005G162300g | 1351.65 |